Nifty
Sensex
:
:
10672.25
35406.62
55.55 (0.52%)
146.08 (0.41%)

Pharmaceuticals & Drugs

Rating :
69/99

BSE: 500420 | NSE: TORNTPHARM

1669.45
-3.10 (-0.19%)
16-Nov-2018 | 11:19AM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  1683.95
  •  1683.95
  •  1663.20
  •  1672.55
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  25684
  •  428.78
  •  1872.80
  •  1221.20

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 28,296.58
  • 45.06
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 33,891.64
  • 0.84%
  • 5.98

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 71.25%
  • 2.19%
  • 6.94%
  • FII
  • DII
  • Others
  • 0.27%
  • 10.22%
  • 9.13%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.88
  • 7.41
  • -3.64

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.89
  • 7.10
  • -13.25

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.91
  • 0.43
  • -26.86

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.04
  • 19.97
  • 22.02

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.48
  • 6.18
  • 5.73

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 12.02
  • 13.28
  • 13.61

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Dec 17
Dec 16
Var%
Net Sales
1,894.00
1,429.00
32.54%
1,872.00
1,362.00
37.44%
1,722.00
1,434.00
20.08%
1,477.00
1,443.00
2.36%
Expenses
1,421.00
1,100.00
29.18%
1,395.00
1,065.00
30.99%
1,358.00
1,139.00
19.23%
1,118.00
1,127.00
-0.80%
EBITDA
473.00
329.00
43.77%
477.00
297.00
60.61%
364.00
295.00
23.39%
359.00
316.00
13.61%
EBIDTM
24.97%
23.02%
25.48%
21.81%
21.14%
20.57%
24.31%
21.90%
Other Income
10.00
78.00
-87.18%
27.00
105.00
-74.29%
42.00
104.00
-59.62%
74.00
50.00
48.00%
Interest
126.00
51.00
147.06%
122.00
56.00
117.86%
121.00
58.00
108.62%
80.00
48.00
66.67%
Depreciation
152.00
84.00
80.95%
150.00
80.00
87.50%
151.00
97.00
55.67%
94.00
73.00
28.77%
PBT
205.00
272.00
-24.63%
232.00
266.00
-12.78%
134.00
244.00
-45.08%
259.00
245.00
5.71%
Tax
26.00
68.00
-61.76%
69.00
78.00
-11.54%
-94.00
38.00
-
201.00
16.00
1,156.25%
PAT
179.00
204.00
-12.25%
163.00
188.00
-13.30%
228.00
206.00
10.68%
58.00
229.00
-74.67%
PATM
9.45%
14.28%
8.71%
13.80%
13.24%
14.37%
3.93%
15.87%
EPS
10.58
12.05
-12.20%
9.63
11.11
-13.32%
13.47
12.17
10.68%
3.43
13.47
-74.54%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Net Sales
6,965.00
5,982.26
5,815.69
6,686.93
4,653.45
4,184.72
3,211.14
2,695.92
2,197.79
1,916.04
1,630.66
Net Sales Growth
22.88%
2.86%
-13.03%
43.70%
11.20%
30.32%
19.11%
22.67%
14.70%
17.50%
 
Cost Of Goods Sold
1,961.00
1,535.17
1,629.66
1,452.21
1,280.96
1,107.58
807.98
774.38
616.64
516.71
487.56
Gross Profit
5,004.00
4,447.09
4,186.03
5,234.72
3,372.49
3,077.14
2,403.16
1,921.54
1,581.16
1,399.32
1,143.10
GP Margin
71.84%
74.34%
71.98%
78.28%
72.47%
73.53%
74.84%
71.28%
71.94%
73.03%
70.10%
Total Expenditure
5,292.00
4,641.21
4,438.42
3,957.13
3,633.29
3,233.24
2,518.92
2,203.54
1,810.01
1,495.26
1,371.93
Power & Fuel Cost
-
118.77
107.98
92.59
97.41
71.88
62.80
56.97
42.53
27.40
25.29
% Of Sales
-
1.99%
1.86%
1.38%
2.09%
1.72%
1.96%
2.11%
1.94%
1.43%
1.55%
Employee Cost
-
1,135.25
993.41
842.35
841.81
741.10
623.29
531.80
440.44
308.33
250.38
% Of Sales
-
18.98%
17.08%
12.60%
18.09%
17.71%
19.41%
19.73%
20.04%
16.09%
15.35%
Manufacturing Exp.
-
457.58
502.16
353.45
345.98
320.78
278.15
225.27
210.89
223.19
200.42
% Of Sales
-
7.65%
8.63%
5.29%
7.43%
7.67%
8.66%
8.36%
9.60%
11.65%
12.29%
General & Admin Exp.
-
718.38
578.05
637.92
477.59
399.07
324.55
255.89
206.88
177.67
150.91
% Of Sales
-
12.01%
9.94%
9.54%
10.26%
9.54%
10.11%
9.49%
9.41%
9.27%
9.25%
Selling & Distn. Exp.
-
633.06
567.70
547.05
574.40
461.53
393.07
322.29
274.61
225.10
197.36
% Of Sales
-
10.58%
9.76%
8.18%
12.34%
11.03%
12.24%
11.95%
12.49%
11.75%
12.10%
Miscellaneous Exp.
-
43.00
59.46
31.56
15.14
131.30
29.08
36.94
18.03
16.85
197.36
% Of Sales
-
0.72%
1.02%
0.47%
0.33%
3.14%
0.91%
1.37%
0.82%
0.88%
3.68%
EBITDA
1,673.00
1,341.05
1,377.27
2,729.80
1,020.16
951.48
692.22
492.38
387.78
420.78
258.73
EBITDA Margin
24.02%
22.42%
23.68%
40.82%
21.92%
22.74%
21.56%
18.26%
17.64%
21.96%
15.87%
Other Income
153.00
307.04
223.30
228.80
285.55
38.13
43.36
52.78
56.23
21.63
23.79
Interest
449.00
308.48
205.56
183.98
175.16
58.63
33.80
39.45
39.13
29.10
39.30
Depreciation
547.00
408.60
306.92
237.55
190.74
87.00
82.69
81.73
62.56
66.09
42.28
PBT
830.00
931.01
1,088.09
2,537.07
939.81
843.98
619.09
423.98
342.33
347.22
200.95
Tax
202.00
252.87
154.51
610.17
188.84
180.07
146.69
72.32
72.17
116.02
7.82
Tax Rate
24.34%
27.16%
14.20%
26.04%
20.09%
21.34%
25.22%
20.17%
21.08%
33.41%
4.07%
PAT
628.00
678.11
933.55
1,733.24
750.94
663.88
432.76
284.04
270.17
231.20
184.37
PAT before Minority Interest
628.00
678.14
933.58
1,733.27
750.97
663.91
434.91
286.30
270.17
231.20
184.37
Minority Interest
0.00
-0.03
-0.03
-0.03
-0.03
-0.03
-2.15
-2.26
0.00
0.00
0.00
PAT Margin
9.02%
11.34%
16.05%
25.92%
16.14%
15.86%
13.48%
10.54%
12.29%
12.07%
11.31%
PAT Growth
-24.06%
-27.36%
-46.14%
130.81%
13.11%
53.41%
52.36%
5.13%
16.86%
25.40%
 
Unadjusted EPS
37.11
40.07
55.17
102.42
44.38
39.23
25.58
33.57
31.93
27.32
21.79

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Shareholder's Funds
4,622.19
4,350.13
3,494.10
2,490.56
1,902.43
1,421.93
1,193.83
1,022.40
830.98
650.89
Share Capital
84.62
84.62
84.62
84.62
84.62
42.31
42.31
42.31
42.31
42.31
Total Reserves
4,537.57
4,265.51
3,409.48
2,405.94
1,817.81
1,379.62
1,151.52
980.10
788.67
608.58
Non-Current Liabilities
4,142.42
2,303.33
1,994.65
2,504.92
926.76
619.81
487.73
397.60
572.29
541.00
Secured Loans
4,105.31
2,229.57
1,839.46
2,171.60
730.72
403.19
223.83
170.59
364.64
318.27
Unsecured Loans
6.15
11.26
10.62
13.62
13.74
51.35
98.22
122.45
157.75
164.33
Long Term Provisions
286.66
263.04
246.36
207.49
190.43
129.51
110.45
56.14
0.00
0.00
Current Liabilities
5,202.17
2,738.26
3,285.48
2,823.75
2,174.58
1,710.65
1,362.84
1,114.09
549.59
465.64
Trade Payables
2,048.24
1,749.32
2,260.22
1,827.72
1,429.13
1,067.74
863.47
615.00
383.60
313.41
Other Current Liabilities
1,151.68
687.14
822.28
446.15
371.63
275.83
291.00
312.85
43.39
60.90
Short Term Borrowings
1,625.60
0.00
3.32
319.07
210.43
124.62
138.12
99.57
0.00
0.00
Short Term Provisions
376.65
301.80
199.66
230.81
163.39
242.46
70.25
86.66
122.60
91.33
Total Liabilities
13,967.30
9,392.21
8,774.69
7,819.66
5,004.17
3,752.76
3,047.90
2,535.69
1,952.86
1,657.53
Net Block
7,854.68
3,688.44
2,859.08
2,832.66
875.34
819.82
796.87
635.55
541.15
511.25
Gross Block
9,449.48
4,909.80
3,793.53
3,542.93
1,420.04
1,278.15
1,199.64
964.28
812.94
720.62
Accumulated Depreciation
1,594.80
1,221.36
934.45
710.27
544.70
458.33
402.77
328.73
271.79
209.37
Non Current Assets
8,704.89
4,512.74
4,085.66
3,768.25
1,599.69
1,191.87
1,060.78
941.27
670.02
583.72
Capital Work in Progress
646.94
519.49
1,041.58
678.33
534.11
285.28
113.55
179.88
109.82
53.42
Non Current Investment
0.09
0.09
0.09
0.06
0.03
0.03
37.52
20.00
19.05
19.05
Long Term Loans & Adv.
149.44
182.32
99.66
206.92
129.47
62.84
61.37
59.51
0.00
0.00
Other Non Current Assets
53.74
122.40
85.25
50.28
60.74
23.90
46.25
46.34
0.00
0.00
Current Assets
5,262.41
4,879.47
4,689.03
4,051.41
3,404.48
2,560.89
1,987.12
1,594.42
1,282.84
1,073.81
Current Investments
492.27
803.55
779.59
297.59
185.63
60.44
86.52
125.99
122.13
120.44
Inventories
1,966.30
1,559.15
1,357.98
1,067.17
1,006.06
923.86
531.56
504.83
323.63
264.54
Sundry Debtors
1,253.45
950.89
1,445.09
1,587.26
1,099.42
687.82
522.80
340.40
298.16
266.58
Cash & Bank
867.26
893.72
647.03
567.36
769.42
626.97
674.28
478.80
388.33
229.99
Other Current Assets
683.13
589.54
369.16
422.94
343.95
261.80
171.96
144.41
150.60
192.26
Short Term Loans & Adv.
96.24
82.62
90.18
109.09
84.95
75.95
56.46
49.28
109.06
157.94
Net Current Assets
60.24
2,141.21
1,403.55
1,227.66
1,229.90
850.24
624.28
480.33
733.26
608.17
Total Assets
13,967.30
9,392.21
8,774.69
7,819.66
5,004.17
3,752.76
3,047.90
2,535.69
1,952.86
1,657.53

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Cash From Operating Activity
894.18
1,008.84
2,742.12
810.20
599.42
153.48
499.13
395.01
287.00
257.90
PBT
931.01
1,088.09
2,343.44
939.81
843.98
581.60
358.62
342.33
347.22
192.19
Adjustment
606.92
430.27
552.44
337.96
136.79
126.13
79.64
74.80
80.63
82.04
Changes in Working Capital
-360.13
-125.21
423.58
-409.38
-119.68
-421.75
143.58
61.88
-74.82
10.12
Cash after chg. in Working capital
1,177.80
1,393.15
3,319.46
868.39
861.09
285.98
581.84
479.01
353.04
284.34
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-283.62
-384.31
-577.34
-58.19
-261.67
-132.50
-82.71
-84.00
-66.04
-26.44
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-4,706.95
-786.91
-837.85
-2,162.30
-355.81
-241.70
-136.97
-232.60
-128.71
-39.58
Net Fixed Assets
-4,245.22
-592.01
-471.42
-2,266.57
-308.01
-455.28
-84.67
-52.13
-152.17
-34.10
Net Investments
310.79
-17.69
-484.32
-111.97
-131.60
287.55
-47.29
-199.04
13.48
-86.91
Others
-772.52
-177.21
117.89
216.24
83.80
-73.97
-5.01
18.57
9.98
81.43
Cash from Financing Activity
3,417.39
-192.91
-1,435.15
1,212.25
86.40
19.73
-192.74
-67.61
-5.25
-18.23
Net Cash Inflow / Outflow
-395.38
29.02
469.12
-139.85
330.01
-68.49
169.42
94.80
153.05
200.09
Opening Cash & Equivalents
1,067.57
1,049.86
612.38
955.05
687.41
760.80
604.79
510.45
350.43
153.84
Closing Cash & Equivalent
702.07
1,067.57
1,049.86
864.95
955.05
687.41
760.80
604.79
510.45
350.43

Financial Ratios

Consolidated /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Book Value (Rs.)
273.11
257.04
206.46
147.16
112.41
84.02
70.54
60.42
49.11
38.46
ROA
5.81%
10.28%
20.89%
11.71%
15.16%
12.79%
10.26%
12.04%
12.81%
12.61%
ROE
15.12%
23.80%
57.92%
34.19%
39.94%
33.25%
25.84%
29.15%
31.20%
31.78%
ROCE
13.81%
20.36%
45.63%
26.98%
35.06%
31.66%
23.65%
25.88%
30.26%
23.12%
Fixed Asset Turnover
0.84
1.35
1.82
1.88
3.11
2.60
2.50
2.48
2.54
2.43
Receivable days
67.03
74.66
82.76
105.19
77.81
68.65
58.33
52.95
52.84
52.49
Inventory Days
107.20
90.90
66.19
81.17
84.02
82.53
70.03
68.69
55.03
54.44
Payable days
151.26
171.27
204.35
176.11
158.58
143.69
136.22
103.96
90.60
83.99
Cash Conversion Cycle
22.96
-5.72
-55.41
10.25
3.25
7.50
-7.86
17.68
17.27
22.94
Total Debt/Equity
1.40
0.58
0.67
1.10
0.59
0.49
0.48
0.56
0.63
0.74
Interest Cover
4.02
6.29
13.74
6.37
15.40
18.21
10.09
9.75
12.93
5.89

News Update:


  • Torrent Pharma - Quarterly Results
    3rd Nov 2018, 16:24 PM

    Read More
  • Torrent Pharma recalling 14 lots of blood pressure tablets from US
    23rd Aug 2018, 11:48 AM

    The company is recalling the said tablets due to presence of impurity

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.